:FGF21

Xiaokun Li1, Zhiheng Rao1, Wenhao Hu2

  • 1School of Pharmaceutical Sciences, Wenzhou Medical University, & Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), Wenzhou, Zhejiang, China.

概括

新的FGF21模仿剂显示出治疗代谢功能障碍相关的脂肪肝炎 (MASH) 的前景. 这些药物有效地减少肝脏脂肪,炎症和损伤,为这种广泛的肝脏疾病提供了潜在的新疗法.